Forcing Canadians to switch from life-changing drugs saves governments millions. Do patients pay a price?

Ontario is the eighth Canadian jurisdiction to switch patients with Crohn's disease and other conditions from life-changing biologic drugs to more cost-effective 'biosimilars.' Both options are considered effective, and the swap saves millions. But should patients be forced to make the change?
Source: CBC | Health - Category: Consumer Health News Tags: News/Health Source Type: news